US and Israel-based medical device company SuperDimension yesterday closed its series B round with $11m of investment from US-based healthcare provider Covidien Ventures, and undisclosed existing investors. SuperDimension’s last round of funding raised $9.8m, in July 2010, from backers including investment firm OrbiMed Advisors, and venture capital firms Oxford Biosciences Partners, Pitango Venture Capital and…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
